Historical review of research and treatment of gastric cancer in Japan: Clinical aspect

The Diversity of Gastric Carcinoma: Pathogenesis, Diagnosis, and Therapy

Volumn , Issue , 2005, Pages 29-47

  Nakajima, Toshifusa ^a  

^a CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 65449153344     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/4-431-27713-7_2     Document Type: Chapter

References (143)

1. Ishikawa K, Sakai S (1996) Historical review. In: Gastric cancer in Japan (in Japanese). Kanehara Shuppan, Tokyo, pp 1-19
2. Shirakabe H, Nishizawa M (1996) X-ray and nuclear diagnosis. In: Gastric cancer in Japan (in Japanese). Kanehara Shuppan, Tokyo, pp 191-217
3. Shirakabe H, Nishizawa N (1996) Mass-screening system. In: Gastric cancer in Japan (in Japanese). Kanehara Shuppan, Tokyo, pp 349-360
4. Ariga K, Takahashi A (1965) Mass screening of gastric cancer (in Japanese). Nanzando, Tokyo, pp 4-5
5. Shirakabe H (1963) Merit and demerit of double contrast method in upper gastrointestinal tract series (in Japanese). Rinshou Kenkyu 40:768-770
6. Sakita T, Takasu Y (1996) Endoscopy, cytology and biopsy diagnosis of gastric cancer. In: Gastric cancer in Japan (in Japanese). Kanehara Shuppan, Tokyo, pp 241-305
7. Uji T (1953) Study on the photography of gastric mucosa and its clinical application (in Japanese). Tokyo Igaku Zasshi 61:135-142
8. Hirschowitz B, Curtiss LE, Peters CW, Pollard HM (1958) Demonstration of new gastro-scope, the "fiberscope." Gastroenterology 35:50-53
9. Tasaka S (1962) Nation-wide registry of early gastric cancer (in Japanese). Gastroenterol Endosc 4:4-14
10. Borrmann R (1926) Geschwulste des Magens und Duodenums. In: Handbuch der speziellen pathologischen Anatomie und Histologie, vol 4. Springer, Berlin, pp 812-1054
11. Murakami T, Nagayo T, Kanai S, et al (1963) Macroscopic classification of early gastric cancer and histopathological examination (in Japanese). Shoukakibyou no Rinshou 5:703-711
12. Inoue Y (1936) Lymphatic system of gastroduodenum, pancreas and diaphragma (in Japanese). Kaibougakuzasshi 9:35-123
13. Ayabe M (1949) So-called early gastric cancer (in Japanese). Rinshou to Kenkyu 26:514-525
14. Schlemper R, Itabashi M, Kato Y, et al (1997) Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists. Lancet 349:1725-1729
15. Kato Y (1999) International concern to early gastric cancer-attempt to standardization of histological diagnosis (in Japanese). Dig Endosc 11:295-299
16. Sugano H, Kato Y (1996) Historical aspect of pathology. In: Gastric cancer in Japan (in Japanese). Kanehara Shuppan, Tokyo, pp 625-641
17. Kuipers E (1999) Review article: exploring the link between Helicobacter pylori and gastric cancer. Aliment Pharmacol Ther 13:3-11
18. Kawamata K (1871) History of gastric cancer (in Japanese). Igakutosho Shuppan, Tokyo
19. Takahama T, Wada T (1996) Surgical treatment. In: Gastric cancer in Japan (in Japanese). Kanehara Shuppan, Tokyo, pp 371-395
20. Kondo T (1899) An experiment in gastric cancer surgery (in Japanese). Nihon Gekagakkai Zasshi 1:234-252
21. Miyake H (1914) Treatment result of gastric cancer with surgery (in Japanese). Chugai Igakushinpo 823:901-902
22. Mutou M (1965) Surgical aspect of gastric cancer (in Japanese). Kanehara Shuppan, Tokyo
23. Tomoda M (1953) Surgery of gastric cancer (in Japanese). Rinshou to Kenkyu 30:300-308
24. Pichlmayr R, van Alste E (1976) Die totale Gastrektomie als Regeloperation beim opera-blen Magencarcinom. Langenbecks Arch Klin Chir 342:227-231
25. Kuru M (1935) Statistical consideration of radical surgery for gastric cancer (in Japanese). Rinshou IIgaku 23:390-390
26. Kajitani T (1944) Lymph node metastasis of gastric cancer (in Japanese). Nihon Gekagakkai Zassi 45:15-16
27. Jinnai D (1961) Extended radical operation of gastric cancer, with special emphasis on the lymph node dissection (in Japanese). Gekashinryou 3:556-556
28. Nakayama K (1949) Gastrectomy with fixation of posterior gastric wall to the pancreas (in Japanese). Shujutu 3:51-56
29. Miyagi J (1928) A variation of gastrectomy. Nihon Gekagakkai Zasshi 29:786-786
30. Gouzi J, Huguier M, Fagniez P, et al (1989) Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A French prospective controlled study. Ann Surg 209:162-166
31. Bozzetti F, Marubini E, Bonfanti G, et al (1999) Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Ann Surg 230:170-178
32. Miwa K (1996) Nationwide registry of gastric cancer and statistics. In: Gastric cancer in Japan (in Japanese). Kanehara Shuppan, Tokyo, pp 465-506
33. Weinberg J, Greaney E (1950) Identification of regional lymph nodes by means of a vital dye during surgery of gastric cancer. Surg Gynecol Obstet 90:561-567
34. Kajitani T, Yamada S (1955) Clinical application of vital lymph node staining with sky blue to radical surgery for gastric cancer (in Japanese). Gan no Rinsho 1:513-516
35. Uchida H (1971) A study on lymphography regional to the stomach and adjacent organs (in Japanese). Nihon Igakuhoushasen Gakkaishi 31:259-277
36. 99mTc-sulfur colloid. Radiology 92:1369-1371
37. Aikou T, Saihara T, Nishi M (1983) Lymph flow at the cardia and lymphatic metastasis of cardiac cancer with special reference to the use of radio-isotope lymphography (in Japanese). Rinpagaku 6:248-252
38. Takahashi S, Takahashi T, Hagiwara A, et al (1987) Lymph node dissection according to the location of gastric cancer with staining of lymph nodes with micro-active carbon particles (in Japanese). Shoukakigeka Gakkai Zasshi 20:720-725
39. Siewert J, Bottcher K, Roder J, et al (1993) Prognostic relevance of systemic lymph node dissection in gastric carcinoma. German Gastric Carcinoma Study Group. Br J Surg 80:1015-1018
40. Pacelli F, Doglietto G, Bellantone R, Alfieri S, Sgadari A, Crucitti F (1993) Extensive versus limited lymph node dissection for gastric cancer: a comparative study of 320 patients. Br J Surg 80:1153-1156
41. Roukos D (1999) Current advances and changes in treatment strategy may improve survival and quality of life in patients with potentially curable gastric cancer. Ann Surg Oncol 6:46-56
42. Sierra A, Regueira F, Hernandez-Lizoain J, et al (2003) Role of the extended lym-phadenectomy in gastric cancer surgery: experience in a single institution. Ann Surg Oncol 10:219-226
43. Bunt A, Hermans J, Boon M, et al (1994) Evaluation of the extent of lymphadenectomy in a randomized trial of Western-versus Japanese-type surgery in gastric cancer. J Clin Oncol 12:417-422
44. Cuschieri A, Weeden S, Fielding J, et al (1999) Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 79:1522-1530
45. Bonenkamp J, Hermans J, Sasako M, et al (1999) Extended lymph-node dissection for gastric cancer. Dutch Gastric Cancer Group. N Engl J Med 340:908-914
46. Pacelli F, Sgadari A, Doglietto G (1999) Surgery for gastric cancer. N Engl J Med 341:538-538
47. Brennan M (1999) Lymph-node dissection for gastric cancer. N Engl J Med 340:956-958
48. Marubini E, Bozzetti F, Bonfanti G, et al Gastrointestinal Tumor Study Group (2002) Lymphadenectomy in gastric cancer: prognostic role and therapeutic implications. Eur J Surg Oncol 28:406-412
49. Yoshioka H, Miyazaki S (1952) A case report of gastric cancer treated with pancreatoduodenectomy (in Japanese). Rinshou Geka 7:231-235
50. Kajitani T, Hoshino T, (1952) An experience of pancreatoduodenectomy (in Japanese). Rin-shougeka 7:231-235
51. Appleby L (1953) The coeliac axis in the expansion of the operation for gastric carcinoma. Cancer (Phila) 6:704-707
52. Wada T, Katayama K, et al (1978) Extent of lymph node dissection in gastric cancer (in Japanese). Geka 40:154-159
53. Ohashi I, Takagi K, Konishi T, et al (1976) 5 year survivors of gastric cancer patients with para-aortic lymph node metastasis (in Japanese). Nihon Shoukakigeka Gakkaishi 9:507-512
54. Aikou T, Yoshinaka H, Shimazu H (1988) Significance and indication of para-aortic lymph node metastasis from esophago-gastric cancer (in Japanese). Gan no Rinshou 34:1677-1683
55. Yamada S, Okajima K, Isozaki H, et al (1989) Evaluation on the indication of para-aortic lymph node dissection in gastric cancer surgery (in Japanese). Nihon Gekagakkaishi 90:1314-1317
56. Takahashi S (1990) Study on the pattern of lymph node metastasis based on the analysis of gastric cancer patients treated with para-aortic dissection (in Japanese). Nihon Gekagakkaishi 91:29-35
57. Keighley M, Moore J, Roginski C, et al (1984) Incidence and prognosis of N4 node involvement in gastric cancer. Br J Surg 71:863-866
58. Ohashi I, Takagi K, Kajitani T (1984) Indication and method of left upper abdominal evisceration for advanced gastric cancer (in Japanese). Shoukakigeka 7:1535-1542
59. Ohyama S, Nakajima T, Ohta K, et al (1994) Left upper abdominal evisceration (in Japanese). Gan to Kagakuryouhou 21:1781-1786
60. Japanese Gastric Cancer Association (2001, 2004) Treatment guidelines of gastric cancer, 1st and 2nd edns (in Japanese). Kanehara Shuppan, Tokyo
61. Takekoshi T, Tajiri H, Ohashi K, et al (1981) Comparative study of biopsy specimen and histological examination: usefulness of endoscopic double snare polypectomy (in Japanese). Nihon Ganchiryougakkaishi 16:395
62. Hirao M, Takakuwa R, Kawashima H, et al (1988) Endoscopic mucosal resection with local injection of hyper saline solution for early gastric cancer (in Japanese). I to Chou 23:399-409
63. Tada M, Murata M, Murakami F, et al (1984) Developing strip-off biopsy (in Japanese). Shoukaki Naishikyou 26:833-836
64. Takeshita K, Inoue H, Honda T, et al (1993) Endoscopic mucosal resection of gastric cancer (in Japanese). Shujutu 47:1537-1546
65. Goh P, Tekant Y, Kum C, et al (1992) Totally intra-abdominal laparoscopic Billroth II gastrectomy. Surg Endosc 6:160
66. Kitano S, Iso Y, Moriyama M, et al (1994) Laparpscopy-assisted Billroth I gastrectomy. Surg Laparoscop Endoscop 4:146-148
67. Uyama I, Ogiwara H, Takahara T, et al (1994) Laparoscopic and minilaparotomy Billroth I gastrectomy for gastric ulcer using an abdominal wall-lifting method. J Laparoscop Surg 4:441-445
68. Japanese Gastric Cancer Association (2001) Commentary of gastric cancer treatment guidelines (in Japanese). JGCA, Tokyo
69. Japanese Gastric Cancer Association (1995) Japanese classification of gastric carcinoma. Kanehara, Tokyo
70. Kurihara M, Nakajima T (1981) Chemotherapy for gastric cancer (in Japanese). Shinkouigaku Shuppan, Tokyo
71. Furue H (1996) Chemotherapy. In: Gastric cancer in Japan (in Japanese). Kanehara Shuppan, Tokyo, pp 423-457
72. Ishidate M, Sakurai Y, Yoshida T, et al (1952) Experimental study of chemotherapy using Yoshida Sarcoma(III); suppression effect of nitrogen-mustard N-oxide (in Japanese). Gann 43:171-174
73. Macdonald JS, Woolley PV, Smythe T, et al (1979) 5-Fluorouracil, adriamycin, and mitomycin C (FAM) combination chemotherapy in the treatment of advanced gastric cancer. Cancer (Phila) 44:42-47
74. Sakata Y, Ohtsu A, Horikoshi N, et al (1998) Late phase II study of novel oral fluoropy-rimidine anticancer drug S-1(1M tegafur-0.4M gimestat-1M otastat potassium) in advanced gastric cancer patients. Eur J Cancer 34:1715-1720
75. Hyodo I, Nishina T, Moriwaki T, et al (2003) A phase I study of S-1 combined with weekly cisplatin for metastatic gastric cancer in an outpatient setting. Eur J Cancer 39:2328-2333
76. Yoshida K, Hirabayashi N, Takiyama W, et al (2004) Phase I study of combination therapy wtih S-1 and docetaxel(TXT) for advanced or recurrent gastric cancer. Anticancer Res 24:1843-1851
77. Mitachi Y, Sakata Y, Ohtsu A, et al (2002) Docetaxel and cisplatin in patients with advanced or recurrent gastric cancer: a multicenter phase I/II study. Gastric Cancer 5:160-167
78. Shirao K, Shimada Y, Kondo H, et al (1997) Phase I-II study of irinotecan hydrochloride combined with cisplatin in patients with advanced gastric cancer. J Clin Oncol 15:921-927
79. Yoshida M, Boku N, Ohtsu A, et al (2001) Combination chemotherapy of irinotecan plus cisplatin for advanced gastric cancer: efficacy and feasibility in clinical practice. Gastric Cancer 4:144-149
80. Skipper H, Schable FJ, Wilcox W (1964) Experimental evaluation of potential anticancer agent. XIII. On the criteria and kinetics associated with curability of experimental leukemia. Cancer Chemother Rep 35:1-111
81. Foley J, Kessinger M, Lemon H (1980) Treatment of breast cancer with oral four-drug chemotherapy. J Surg Oncol 14:67-72
82. Tucker R, Ferguson A, Van Wyk C, et al (1978) Chemotherapy of small cell carcinoma of the lung with V.P.16 213. Cancer (Phila) 41:1710-1714
83. Hahn R, Moertel C, Schutt A, et al (1975) A double-blind comparison of intensive course 5-fluorouracil by oral vs intravenous route in the treatment of colorectal carcinoma. Cancer (Phila) 35:1031-1035
84. Chlebowski R, Paroly W, Pugh R, et al (1979) Treatment of advanced gastric carcinoma with 5-fluorouracil: randomized comparison of two routes of delivery. Cancer Treat Rep 63:1979-1981
85. Bedikian A, Staab R, Livingston R, et al (1978) Chemotherapy for colorectal cancer with 5-fluorouracil, cyclophosphamide, and CCNU: comparison of oral and continuous iv administration of 5-fluorouracil. Cancer Treat Rep 62:1603-1605
86. Carmichael J, Popiela T, Radstone D, et al (2002) Randomized comparative study of Tegafur/Uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 20:3617-3627
87. Douillard J-Y, Hoff P, Skillings J, et al (2002) Multicenter phase III study of Uracil/Tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 20:3605-3616
88. Shirao K, Hoff P, Ohtsu A, et al (2004) Comparison of the efficacy, toxicity and pharmacokinetics of a Uracil/Tegafur(UFT) plus oral leucovorin(LV) regimen between Japanese and American patients with advanced colorectal cancer: Joint United State and Japan Study of UFT/LV. J Clin Oncol 22:3466-3474
89. Feliu S, Gonzalez Baron M, Garcia-Giron C, et al (1996) Treatment of patients with advanced gastric carcinoma with the combination of etoposide plus oral tegafur modulated by uracil and leucovorin. Cancer (Phila) 78:211-216
90. Koizumi W, Kurihara M, Sasai T, et al (1993) A phase II study of combination therapy with 5'-deoxy-5-fluorouridine and cisplatin in the treatment of advanced gastric cancer with primary foci. Cancer (Phila) 72:658-662
91. Koizumi W, Kurihara M, Hasegawa K, et al (1996) Combination therapy with cisplatin, 5'-deoxy-5-fluorouridine(5'-DFUR) and mitomycin (MMC) in patients with inoperable, advanced gastric cancer: a randomized trial comparing two dosage regimens. Oncol Rep 3:255-260
92. Koizumi W, Kurihara M, Nakano S, et al (2000) Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. Oncology 58:191-197
93. Koizumi W, Tanabe S, Ohtsu A, et al (2003) Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer. Br J Cancer 89:2207-2212
94. Hoff P, Pazdur R, Benner S, et al (1998) UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer. Anti-cancer Drugs 9:479-490
95. Inokuchi K, Akiyoshi T (1962) Catheterization into the caeliac artery for local chemotherapy (in Japanese). Shujutu 16:601-604
96. Watkins E Jr, Sullivan R (1964) Cancer chemotherapy by prolonged arterial infusion. Surg Gynecol Obstet 118:3-19
97. Miura K, Sugiura M, Ishida S, et al (1966) Intra-arterial chemotherapy with Watkins' portable infusion pump (in Japanese). Ikakikaigaku Zasshi 36:504-508
98. Miura K, Wada T, Haida H, et al (1982) Subdermal implantable continuous infusion pump: Infusaid (in Japanese). Shujutu 36:1449-1458
99. Stephens FO, Adams BG, Crea P (1986) Intra-arterial chemotherapy given preoperatively in the management of carcinoma of the stomach. Surg Gynecol Obstet 162:370-374
100. Arai Y, Kido C, Endo T, et al (1989) Intra-arterial FAM chemotherapy for gastric cancer patients with liver metastasis (in Japanese). Gan to Kagakuryouhou 15:2433-2436
101. Aigner KR, Benthin F, Muler H (1991) Celiac axis infusion (CAI) chemotherapy for advanced gastric cancer. In: Sugarbaker PH (ed) Management of gastric cancer. Kluwer, Boston, pp 357-362
102. Nakajima T, Ota K, Ishihara S, et al (1997) Combined intensive chemotherapy and radical surgery for incurable gastric cancer. Ann Surg Oncol 4:203-208
103. Takahashi Y, Mai M, Taguchi T, et al (2000) Prolonged stable disease effects survival in patients with solid gastric tumor: analysis of phase II studies of doxifluridine. Int J Oncol 17:285-289
104. Takahashi Y, Nishioka K (1995) Survival without tumor shrinkage: re-evaluation of survival gain by cytostatic effect of chemotherapy. J Natl Cancer Inst 87:1262-1263
105. Japanese Society of Clinical Oncology (1986) Response evaluation criteria of chemotherapy for solid cancer (in Japanese). J Jpn Soc Clin Oncol 21:929-942
106. Therasse P, Arbuch S, Eisenhauer E, et al (2000) New guideline to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92:205-216
107. JCOG (1999) NCI-CTC (in Japanese). Gan to Kagakuryouhou 26:1084-1144
108. Nakajima T, Nishi M (1988) Adjuvant chemotherapy, immunochemotherapy, and neoadjuvant therapy for gastric cancer in Japan. In: Douglass HO Jr (ed) Gastric cancer, vol 8. Churchill Livingstone, New York, pp 125-143
109. Nakajima T (1990) Adjuvant chemotherapy for gastric cancer in Japan: present status and suggestions for rational clinical trials. Jpn J Clin Oncol 20:30-42
110. Sano T, Sasako M, Katai H, et al (1999) Randomized controlled trials on adjuvant therapy for gastric cancer: Japanese experience. In: Nakajima T, Yamaguchi T (eds) Multimodality therapy for gastric cancer. Springer-Verlag, Tokyo, pp 7-16
111. Imanaga H, Nakazato H (1977) Results of surgery for gastric cancer and effect of adjuvant mitomycin C on cancer recurrence. World J Surg 1:213-221
112. Nakajima T, Fukami A, Ohashi I, et al (1978) Long-term follow-up study of gastric cancer patients treated with surgery and adjuvant chemotherapy with mitomycin C. Int J Clin Pharmacol 16:209-216
113. Nakajima T, Fukami A, Takagi K, et al (1980) Adjuvant chemotherapy with mitomycin C, and with a multi-drug combination of mitomycin C, 5-fluorouracil and cytosine arabi-noside after curative resection of gastric cancer. Jpn J Clin Oncol 10:187-194
114. Inokuchi K, Hattori T, Taguchi T, et al (1984) Postoperative adjuvant chemotherapy for gastric carcinoma. Analysis of data on 1805 patients followed for 5 years. Cancer (Phila) 53:2393-2397
115. Nakazato H, Koike A, Saji S, Ogawa N, Sakamoto J (1994) Efficacy of immunochemother-apy as adjuvant treatment after curative resection of gastric cancer. Lancet 343:1122-1126
116. Arima S, Ohsato K, Hisatsugu T, Shimura H (1994) Multicenter randomized study of adjuvant chemotherapy with mitomycin c and tegafur or tegafur-uracil in gastric cancer. Eur J Surg 160:227-232
117. Furukawa H, Iwanaga T, Nakajima T, et al (1995) Randomized study with mitomycin C + 5-fluorouracil, cytosine arabinoside (MFC) + 5-fluorouracil, MFC + Tegafur and Uracil (UFT), and MF + UFT in advanced gastric cancer: interinstitutional differences in a multicenter study in Japan. J Surg Oncol 60:59-64
118. Sugimachi K, Maehara Y, Ogawa M, et al (1997) Dose intensity of uracil and tegafur in postoperative chemotherapy for patients with poorly differentiated gastric cancer. Cancer Chemother Pharmacol 40:233-238
119. Nakajima T, Nashimoto A, Kitamura M, et al (1999) Adjuvant mitomycin and fluorouracil followed by oral uracil plus tegafur in serosa-negative gastric cancer: a randomized trial. Lancet 354:273-277
120. Nakajima T (2000) Evaluation of adjuvant UFT for gastric cancer. Oncology 14:82-86
121. Nashimoto A, Nakajima T, Furukawa H, et al (2003) Randomized trial of adjuvant chemotherapy with mitomycin, fluorouracil, and cytosine arabinoside followed by oral fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1. J Clin Oncol 21:2282-2287
122. Hermans J, Bonenkamp H (1994) In reply to the editor. J Clin Oncol 12:879-880
123. Nakajima T, Ohta K, Ishihara S, et al (1994) Evaluation of adjuvant chemotherapy in gastric cancer with meta-analysis. Cancer Chemother 21:1800-1805
124. Nakajima T, Ohta K, Ohyama S, et al (1999) Meta-analysis of adjuvant chemotherapy trials for gastric cancer at the Cancer Institute Hospital, Tokyo. In: Nakajima T, Yamaguchi T (eds) Multimodality therapy for gastric cancer. Springer-Verlag, Tokyo, pp 27-31
125. Earle C, Maroun J (1999) Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomized trials. Eur J Cancer 35:1059-1064
126. Mari E, Floriani I, Tinassi A, et al (2000) Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomized trials. Ann Oncol 11:837-843
127. Panzini I, Gianni L, Fattori P, et al (2002) Adjuvant chemotherapy in gastric cancer: a metaanalysis of randomized trials and a comparison with previous meta-analyses. Tumori 88:21-27
128. Frei E, Miller ID, Clark JR, et al (1986) Clinical and scientific considerations in preoperative (neoadjuvant) chemotherapy. Recent Results Cancer Res 103:1-5
129. Yonemura Y, Sawa T, Kinoshita K, et al (1993) Neoadjuvant chemotherapy for high-grade advanced gastric cancer. World J Surg 17:256-261
130. Suga S, Iwase H, Shimada M, et al (1996) Neoadjuvant chemotherapy in scirrhous cancer of the stomach using uracil and tegafur and cisplatin. Intern Med 35:930-936
131. Tei Y, Yamashita Y, Nakada B, et al (1995) Clinical effect of continuous iv 5-FU and low-dose daily CDDP regimen for advanced and recurrent gastric cancer (in Japanese). Gan to Kagakuryouhou 22:149-151
132. Kondou T, Murase M, Yokoyama T, et al (1996) Preoperative chemotherapy with continuous 5-FU and low-dose daily CDDP regimen for advanced and recurrent gastric cancer (in Japanese). Gan to Kagakuryouhou 23:1299-1303
133. Chung Y, Yamashita Y, Inoue T (1997) Continuous infusion of 5-fluorouracil and low dose cisplatin infusion for the treatment of advanced and recurrent gastric adenocarcinoma. Cancer 80:1-7
134. Saikawa Y, Kanai T, Kawano Y, et al (2002) An experience ofTS-1, low-dose CDDP regimen for gastric cancer patients with liver metastasis (in Japanese). Gan to Kagakuryouhou 29:1241-1245
135. Kelsen D, Ginsberg R, Pajak T, et al (1998) Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339:1979-1984
136. Songun I, Keizer H, Hermans J, et al (1999) Chemotherapy for operable gastric cancer: results of the Dutch randomized FAMTX trial. Eur J Cancer 35:558-562
137. Yamamoto T, Komechi T, Nishioka K, et al (1956) Cell agar plate (CAP) method as a chemo-sensitivity test (in Japanese). Gann 47:424-426
138. Nishioka K, Takehiko T, Yamamoto T, et al (1959) Chemo-sensitivity test for human anticancer virus and drugs (in Japanese). Nihon Rinshou 15:23-34
139. Ishibashi Y, Fujii G, Okada S (1957) Screening test for anti-cancer drugs with human cancer tissues (in Japanese). Rinshou no Nihon 3:141-149
140. Kondou T, Ichihashi H, Imamura T, et al (1964) Screening test of anti-cancer drugs (in Japanese). Gan no Rinshou 10:17-21
141. Ohsawa N (1975) Chemotherapy to the xenograft of human cancer tissue in nude mouse (in Japanese). Rinshou Seijinbyou 5:1039-1045
142. Tanigawa N (2004) Chemotherapy for gastrointestinal cancer (in Japanese). Nihon Medical Center, Tokyo, pp 7-57
143. Kubota T, Sasano N, Abe O (1995) Potential of the histoculture drug-responce assay to contribute to cancer patients survival. Clin Cancer Res 1:1537-1543